Anthropic's AI tool, who own this, is it publicly listed in North American stocks market

**Bottom-line 🏁** Anthropic is a privately-held company; its core AI tool “Claude” is therefore **not listed on any North-American exchange**. The firm is majority-owned by its co-founders, Dario and Daniela Amodei, with significant minority stakes from marquee venture funds such as GIC, Coatue, D. E. Shaw Ventures, Dragoneer, Founders Fund, ICONIQ and MGX. 🚀🤖 --- ### Ownership snapshot 🧐 | Ownership Tier | Key Holders | Governance Rights | Economic Stake | Source | |----------------|-------------|-------------------|----------------|--------| | Founders | Dario & Daniela Amodei | Majority control of code, roadmap & safety policies | Majority economic upside | | | Venture Funds | GIC, Coatue, D. E. Shaw, Dragoneer, Founders Fund, ICONIQ, MGX | Minority, non-controlling | Economic upside via equity | | *Why the table?* It highlights the clear split between operational control (founders) and capital backing (VCs), a structure that keeps Anthropic mission-aligned while funding aggressive growth. 📊✨ --- ### Why it’s not publicly tradable (yet) 📉 1. **Private status:** Anthropic has not filed an S-1 or completed an IPO; the latest update is a $30 billion Series G round at a $380 billion post-money valuation. 2. **No exchange listing:** There is no ticker symbol on NASDAQ, NYSE or TSX. Investors must rely on secondary-market trades or venture exposure for indirect participation. 3. **Strategic timing:** Management has signaled a focus on “frontier research” and enterprise adoption rather than near-term listing, suggesting an IPO may wait until the company hits specific scale or regulatory milestones. --- ### What this means for you 🧭 • **No direct stock purchase:** You can’t buy “ANCT” on Robinhood or Bloomberg. • **Indirect exposure:** Consider complementing your tech watch-list with partners such as AWS, Google Cloud or NVIDIA, which benefit from Anthropic’s compute and integration needs. • **Secondary-market options:** Some venture platforms allow accredited investors to trade private-equity shares, but these carry liquidity and information-asymmetry risks. --- **Curious next step 🤓** If Anthropic delays going public, which of your current high-growth holdings could serve as a “proxy play” while you wait for a potential IPO—or would you rather explore private-market secondary opportunities sooner? 🧐💬